San Diego, California — BioHarvest Sciences shared an optimistic update during its third quarter 2025 corporate conference call, highlighting a significant enhancement in operational performance. The meeting featured Chief Executive Officer Ilan Sobel and Chief Financial Officer Bar Dichter, who detailed the company’s achievements and future outlook.
Sobel opened the call with a warm welcome, expressing satisfaction over the company’s continued revenue growth in the third quarter. He emphasized the importance of maintaining a strong operational performance amid the challenges facing the industry. This ongoing progress is vital as BioHarvest positions itself within the competitive landscape of biotechnology.
As part of the call, the executives underscored that any forward-looking statements might carry risks and uncertainties, which could lead to outcomes differing from the expectations outlined in their projections. They encouraged participants to consult the company’s regulatory filings for a comprehensive list of these risks.
Throughout the discussion, the leaders highlighted adjusted EBITDA as a significant financial metric, distinct from traditional IFRS measures. This metric is intended to give investors valuable insights into the company’s ongoing business performance. A precise reconciliation of this measure was provided in their earnings release, accessible on the BioHarvest website.
Dichter presented insights into the company’s financial health, reporting metrics that indicate positive trends and operational efficiencies. He noted that the revenue increase was driven by new product launches and expanding market penetration. This momentum, according to Dichter, reflects the effectiveness of their strategic initiatives.
Sobel further elaborated on the company’s innovative approaches and their commitment to research and development. He affirmed that BioHarvest is dedicated to fostering innovation, which will remain central to their growth strategy. “We aim to stay at the forefront of this rapidly evolving industry,” he stated.
Additionally, both executives addressed the importance of sustainability in their business model. They reiterated BioHarvest’s commitment to environmentally responsible practices, which they believe will resonate well with consumers in today’s market.
Looking ahead, Sobel and Dichter expressed optimism about the company’s trajectory and outlined their plans for continued growth into the coming quarters. Their confidence is bolstered by a strong product pipeline and strategic partnerships that they believe will enhance the company’s position in the marketplace.
The details shared during the call not only showcased BioHarvest’s achievements but also set the stage for what lies ahead as they navigate the complexities of the biotechnology sector.
